Annual report pursuant to Section 13 and 15(d)

Segment Information (Details)

v3.21.1
Segment Information (Details) - USD ($)
12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Segment information    
Revenue $ 29,947,000 $ 29,956,000
Cost of revenue 19,875,000 20,309,000
Gross profit $ 10,072,000 $ 9,647,000
Gross margin 33.60% 32.20%
Research and development $ 4,032,000 $ 5,346,000
Segment Profit Loss 6,040,000 4,301,000
Operating expenses    
Sales and marketing 5,207,000 7,592,000
General and administrative 4,086,000 4,757,000
Intangible amortization 903,000 1,233,000
Restructuring 0 234,000
Impairment of Long-Lived Assets to be Disposed of 525,000 1,007,000
Operating income (loss) (4,681,000) (10,522,000)
Gain (Loss) on Extinguishment of Debt 1,637,000  
Other income (expense), net 288,000 456,000
Income tax benefit (expense) 22,000 (36,000)
Net income (loss) from continuing operations (2,734,000) (10,102,000)
IBW [Member]    
Segment information    
Revenue 9,683,000 10,021,000
Cost of revenue 7,159,000 7,408,000
Gross profit $ 2,524,000 $ 2,613,000
Gross margin 26.10% 26.10%
Research and development $ 1,596,000 $ 1,757,000
Segment Profit Loss 928,000 856,000
ISM [Member]    
Segment information    
Revenue 9,352,000 10,101,000
Cost of revenue 4,108,000 4,865,000
Gross profit $ 5,244,000 $ 5,236,000
Gross margin 56.10% 51.80%
Research and development $ 1,623,000 $ 2,237,000
Segment Profit Loss 3,621,000 2,999,000
CNS [Member]    
Segment information    
Revenue 10,912,000 9,834,000
Cost of revenue 8,608,000 8,036,000
Gross profit $ 2,304,000 $ 1,798,000
Gross margin 21.10% 18.30%
Research and development $ 813,000 $ 1,352,000
Segment Profit Loss $ 1,491,000 $ 446,000